PerkinElmer

Waltham, United States Founded: 1931 • Age: 95 yrs
Medical instruments and supplies are manufactured and provided for healthcare.

About PerkinElmer

PerkinElmer is a company based in Waltham (United States) founded in 1931. The company has 219 employees. PerkinElmer has completed 35 acquisitions, including ArtusLabs, BioLegend and Caliper Life Sciences. PerkinElmer operates in a competitive market with competitors including Cytiva, Labviva, Zageno, Fortis Life Sciences and Leica Biosystems, among others.

Key Metrics
  • Net Profit
    $727.89 M (USD)
    220
    as on Dec 31, 2020
  • EBITDA
    $978.58 M (USD)
    170
    as on Dec 31, 2020
  • Latest Funding Round
    $500M (USD), Debt – Conventional

    Aug 2021

  • Investors
  • Employee Count
    219
  • Investments & Acquisitions
    ArtusLabs

    & 34 more

Funding Insights of PerkinElmer

  • Total Rounds 21
  • Last Round Debt – Conventional β€” $500M
  • Investors Count 1

Latest 10 of 21 funding rounds of PerkinElmer with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2021$500MDebt – Conventional––
–
Feb 2021$21,663Grant––
Nov 2020$185,448Grant––
Nov 2020$63,073Grant––
Dec 2019$145,574Grant––
Nov 2019$166,543Grant––
Sep 2019$850MDebt – Conventional––
–
Sep 2019$1BDebt – Conventional––
–
Feb 2019$20,214Grant––
Dec 2018$160,738Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in PerkinElmer

PerkinElmer has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for PerkinElmer

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of PerkinElmer

The boards of the 3 registered companies of PerkinElmer currently have 8 directors; the longest-serving is Seshadri Suresh, appointed in 2009. 29 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Seshadri Suresh
DIN 00136404
Director04 Sep 200917 yrs 1 moRevvity Health Sciences Private Limited
John Leo Healy
DIN 02819115
Director15 Dec 200916 yrs 9 moRevvity Health Sciences Private Limited
Alok Kumar
DIN 05119699
Director16 Nov 201114 yrs 10 moRevvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited, Tulip Diagnostics Private Limited
Jayashree Kailas Thacker
DIN 07105039
Director17 Mar 201511 yrs 6 moRevvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited
Deepak Gurushankar Tripathi
DIN 02021472
Director05 May 20179 yrs 5 moTulip Diagnostics Private Limited
Narendra Makkar
DIN 07940889
Director19 Sep 20179 yrsTulip Diagnostics Private Limited
Shripad Digamber Rao Joshi
DIN 08825256
Director07 Aug 20206 yrs 2 moRevvity Healthcare (India) Private Limited
Ajita Rahul Pansare
DIN 11027887
Additional Director01 Apr 20251 yr 6 moRevvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited

People of PerkinElmer

337 people are tracked at PerkinElmer (73 in leadership, 9 in board & advisors, 255 in team); the tracked headcount is 219.

NameRoleGroup
Prahlad Singh
CEOLeadership
Kris Leong
Japan GM And Country PresidentLeadership
Alexey Sosnovskiy
Chief Of Staff | Head Of Value Creation OfficeLeadership
Dana Schaaf
Talent Acquisition PartnerLeadership
Erica Johnson
Senior Talent Acquisition PartnerLeadership
John Kavanagh
Head Of Infrastructure & OperationsLeadership
Dian Chen
VP Of Product PortfolioLeadership
Johan Lundin
Vice President Special ProjectsLeadership
Geoffray Colson
Vice President Global QualityLeadership
Joe Roach
Chief Technology OfficerLeadership
Rosemary Pitts
Chief Financial OfficerLeadership
Kris Keegan
Vice President, General Counsel, Discovery & Analytical SolutionsLeadership
Jim Plassard
Scientific Services General Manager, OnesourceLeadership
Brian Holbrook
Director Global Indirect ProcurementLeadership
Dale Durham
Sr. Director, Global Services, Technical Support And TrainingLeadership
Walter Faraci
General Manager - Onesource EnterpriseLeadership
Robert Hannagan
Director Of OperationsLeadership
Gracie Chen
HR Director, DAS APACLeadership
Guido Lerch
Sr. Director, Quality & Compliance | Cloud Governance - InformaticsLeadership
Scott Greenwood
General Manager - OnesourceLeadership

317 more people are available in the full profile.

Premium access

Complete people profiles for PerkinElmer

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of PerkinElmer

Figures of Revvity Healthcare (India) Private Limited, the primary company behind PerkinElmer, for FY 2025. Revenue was ₹238 Cr (+3% year on year). Net profit was ₹6.83 Cr (3% margin). EBITDA was ₹21.44 Cr (9% margin). Revenue has grown at a compounded annual rate of +40% over three years and +1% over five years.

  • ₹238 CrRevenue · FY 2025 · +3% YoY
  • ₹6.83 CrNet profit · 3% margin
  • ₹21.44 CrEBITDA · 9% margin
  • ₹4.28 CrPaid-up capital
  • +40%Revenue CAGR, 3 years
  • +1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Revvity Healthcare (India) Private Limited are on its company page.

Premium access

Detailed financial statements for PerkinElmer

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PerkinElmer

PerkinElmer has strategically engaged in corporate development activities, having acquired 35 companies. Notable acquisitions include ArtusLabs, BioLegend and Caliper Life Sciences.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of consulting, quality, regulatory, and marketing services to biopharma sector
projectfarma.comBethesda, United States2013Mar 2025β€’β€’β€’β€’
Sample preparation platforms using ultrasonic acoustics
covaris.comWoburn, United States1998Dec 2023β€’β€’β€’β€’
Preclinical ultrasonic imaging of tissue and vasculature is provided.
sonovol.comDurham, United States2012Feb 2022β€’β€’β€’β€’
Immunological reagents are developed and manufactured for biomedical research.
biolegend.comSan Diego, United States2002Jul 2021$5.25B
Customized AAV-based viral vectors for gene therapy are supplied.
sirion-biotech.comPlanegg, Germany2005Jun 2021β€’β€’β€’β€’
Immunoassays and automated analyzers for endocrinology are developed and marketed.
idsplc.comEast Boldon, United Kingdom1977May 2021$155M
Automated cell counting and imaging solutions are developed for cytometry.
nexcelom.comLawrence, United States2003May 2021$260M
Developer of high performance bonded phases and packing materials for HPLC and SFC
esind.comWest Berlin, United States1962Mar 2021β€’β€’β€’β€’
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
oxfordimmunotec.comAbingdon, United Kingdom2002Jan 2021$591M
Genetically modified cell lines are developed using AAV gene-editing platform.
horizondiscovery.comCambridge, United Kingdom2007Nov 2020$383M
Premium access

Complete acquisition details for PerkinElmer

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of PerkinElmer

13 dated milestones of PerkinElmer across 94 years, from founding to its latest funding, stage changes and deals.

  1. Founded PerkinElmer is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Horizon Discovery.
  4. Acquisition Acquires Oxford Immunotec.
  5. Acquisition Acquires ES Industries.
  6. Acquisition Acquires Nexcelom Bioscience.
  7. Acquisition Acquires Immunodiagnostic Systems.
  8. Acquisition Acquires Sirion Biotech.
  9. Acquisition Acquires BioLegend.
  10. Funding Latest funding round, Debt – Conventional, of $500.0M.
  11. Acquisition Acquires SonoVol.
  12. Acquisition Acquires Covaris.
  13. Acquisition Acquires Project Farma.

Competitors of PerkinElmer

PerkinElmer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytiva, Labviva, Zageno, Fortis Life Sciences and Leica Biosystems, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cytivalifesciences.com1968Sheffield, United Kingdom–578
Life science software and research products are provided online.
labviva.com2017Cambridge, United States$55.75M8
An AI-powered marketplace for life science products is operated.
zageno.com2015Cambridge, United States$120.93M51
Marketplace and life science research community for biotech research kits
fortislife.com2020Waltham, United States––
A trusted partner in life sciences and diagnostics solutions.
leicabiosystems.com1989Nussloch, Germany–365
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
meenta.io2016Boston, United States$2.47M–
Operates a digital marketplace for sequencing instruments.
celltreat.com2008Pepperell, United States––
Produces laboratory plastic consumables like pipets and vials for efficient scientific research.
Premium access

Detailed competitors of PerkinElmer

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of PerkinElmer

The website of PerkinElmer (perkinelmer.com) receives about 164.5K visits a month.

  • Monthly visits
    164.5K

    ▼ 4.5% vs previous month

Similar websites

Websites whose visitors overlap most with PerkinElmer. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cambridgesoft.com
100%
––View details
tainstruments.com
99%
–#320,048View details
waters.com
92%
416.8K#124,184View details
shimadzu.com
90%
271K#178,629View details
chem.agilent.com
chem.agilent.com
81%
–––
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for PerkinElmer

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Perkinelmer

Premium access

Complete news archive for PerkinElmer

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to PerkinElmer

10 companies that operate in the same segment as PerkinElmer (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PerkinElmer

PerkinElmer was founded in 1931 and raised its 1st funding round 83 years after it was founded.

PerkinElmer is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Prahlad Singh is the current CEO of PerkinElmer.

PerkinElmer has 219 employees.

Provider and manufacturer of medical instruments and supplies for the healthcare industry. The company has an online selling platform for medical instruments such as medical imaging, atomic spectroscopy, automation liquid handling, cell harvesters, chromatography, cytogenetics, content screening, hyphenated technology devices, and more. In 2022, the company recorded annual revenues of 3.94B and a net profit of 0.56B.

PerkinElmer's top competitors include Labviva, Cytiva and Zageno.

PerkinElmer has made 35 acquisitions, including ArtusLabs, BioLegend, and Caliper Life Sciences.

PerkinElmer has 1 investor. Key investors include European Union.

PerkinElmer is associated with 3 legal entities: Revvity Healthcare (India) Private Limited, Revvity Health Sciences Private Limited, Tulip Diagnostics Private Limited.

The legal entities of PerkinElmer currently have 8 directors, including Shripad Digamber Rao Joshi, Alok Kumar, Jayashree Kailas Thacker and others.

The website of PerkinElmer receives about 165 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available